- What Are Tesamorelin and Ipamorelin?
- Why People Ask About the Combination
- What the Evidence Actually Shows
- FDA Status and Safety Considerations
- Who Should Be Careful or Avoid This Discussion
- How We Handle Tesamorelin + Ipamorelin Consultations at Vitalé
- Peptide Consultations in Manasquan and Online
- Schedule an Online Consultation
Medically Supervised Consultations in Manasquan and Online
Vitalé provides peptide consultation services from its Manasquan, NJ clinic and may offer online consultations for eligible patients where permitted. Availability depends on your location, medical history, treatment goals, provider review, and applicable state requirements.
Tesamorelin + Ipamorelin is often marketed online as a body-composition or longevity stack. The problem is that these two compounds do not sit in the same regulatory category, and the evidence base is not symmetrical.
- Tesamorelin is a prescription drug with a specific FDA-approved indication.
- Ipamorelin is not FDA-approved and has been reviewed within the FDA’s compounding and bulk-substance evaluation process.
At Vitalé, this combination is treated as a high-caution discussion, handled entirely through secure online medical consultations for patients across the United States. The focus is on what each compound is, what the FDA-approved use is (and is not), and what risks or unknowns exist.
What Are Tesamorelin and Ipamorelin?
Tesamorelin (Egrifta WR/Egrifta SV)
Tesamorelin is a growth hormone–releasing hormone (GHRH) analogue. It stimulates the pituitary gland to increase endogenous growth hormone secretion, which in turn raises IGF-1 levels.
FDA-approved use:
- Reduction of excess abdominal fat in adults with HIV-associated lipodystrophy
Tesamorelin is not approved for weight-loss management, longevity therapy, or general body recomposition.
Ipamorelin
Ipamorelin is commonly described as a growth hormone–releasing peptide acting through the ghrelin-receptor pathway. It has been studied in pharmacologic contexts for its effects on GH release.
Important context:
- Ipamorelin is not FDA-approved
- It is not approved for weight loss, longevity, or body recomposition
- Human clinical outcome data is limited
Why People Ask About the Combination
People usually ask about Tesamorelin + Ipamorelin because they are seeking outcomes such as:
- Visceral fat reduction
- Improved recovery or sleep
- “Metabolic reset” or anti-aging effects
- Lean mass support
Here is the reality:
Tesamorelin’s FDA-approved evidence applies to a specific population and endpoint, and there is no strong human clinical evidence showing that stacking it with Ipamorelin improves outcomes for body composition, longevity, or performance in the general population.
People usually ask about Tesamorelin + Ipamorelin because they are seeking outcomes such as:
- Visceral fat reduction
- Improved recovery or sleep
- “Metabolic reset” or anti-aging effects
- Lean mass support